Bereich
Infektiologie | Infektionsprävention | Reisemedizin
INFEKT · Dept. I
Infrequent transmission of HIV-1 drug-resistant variants
Yerly S, Perrin L, Hirschel B, Perneger T, Bernard M, Gebhardt M, Rickenbach M, Bürgisser P, Chanzy B, Furrer H, Battegay M, Vernazza P, Chave J, Kaiser L, Flepp M, Telenti A, Jost S, Swiss HIV Cohort Study. Infrequent transmission of HIV-1 drug-resistant variants. Antiviral therapy 2004; 9:375-84.
01.06.2004Infrequent transmission of HIV-1 drug-resistant variants
01.06.2004Antiviral therapy 2004; 9:375-84
Yerly Sabine, Perrin Luc, Hirschel Bernard, Perneger Thomas, Bernard Marie-Charlotte, Gebhardt Martin, Rickenbach Martin, Bürgisser Philippe, Chanzy Bruno, Furrer Hansjakob, Battegay Manuel, Vernazza Pietro, Chave Jean-Philippe, Kaiser Laurent, Flepp Markus, Telenti Amalio, Jost Stéphanie, Swiss HIV Cohort Study
Brief but efficient: acute HIV infection and the sexual transmission of HIV
Pilcher C, Quest Study, Cohen M, Goh L, Stewart P, Leu S, Vernazza P, Eron J, Tien H, Duke-UNC-Emory Acute HIV Consortium. Brief but efficient: acute HIV infection and the sexual transmission of HIV. The Journal of infectious diseases 2004; 189:1785-92.
15.05.2004Brief but efficient: acute HIV infection and the sexual transmission of HIV
15.05.2004The Journal of infectious diseases 2004; 189:1785-92
Pilcher Christopher D, Quest Study, Cohen Myron S, Goh Li-Ean, Stewart Paul W, Leu Szu-Yun, Vernazza Pietro, Eron Joseph J, Tien Hsiao Chuan, Duke-UNC-Emory Acute HIV Consortium
Sexual risk behavior in HIV-infected injection drug users
Battegay M, Bucher H, Vernazza P. Sexual risk behavior in HIV-infected injection drug users. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004; 38:1175-7.
15.04.2004Sexual risk behavior in HIV-infected injection drug users
15.04.2004Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004; 38:1175-7
Battegay Manuel, Bucher Heiner C, Vernazza Pietro
Ritonavir boosted indinavir treatment as a simplified maintenance "mono"-therapy for HIV infection
Kahlert C, Hupfer M, Wagels T, Büche D, Fierz W, Walker U, Vernazza P. Ritonavir boosted indinavir treatment as a simplified maintenance "mono"-therapy for HIV infection. AIDS (London, England) 2004; 18:955-7.
09.04.2004Ritonavir boosted indinavir treatment as a simplified maintenance "mono"-therapy for HIV infection
09.04.2004AIDS (London, England) 2004; 18:955-7
Kahlert Christian, Hupfer Maria, Wagels Thomas, Büche Daniel, Fierz Walter, Walker Ulrich A, Vernazza Pietro
Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection
Kaufmann G, Battegay M, Hirschel B, Rickenbach M, Bernasconi E, Vernazza P, Ledergerber B, Cavassini M, Furrer H, Perrin L, Weber R, Khanna N, Swiss HIV Cohort Study. Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection. Antiviral therapy 2004; 9:263-74.
01.04.2004Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection
01.04.2004Antiviral therapy 2004; 9:263-74
Kaufmann Gilbert R, Battegay Manuel, Hirschel Bernard, Rickenbach Martin, Bernasconi Enos, Vernazza Pietro, Ledergerber Bruno, Cavassini Matthias, Furrer Hansjakob, Perrin Luc, Weber Rainer, Khanna Nina, Swiss HIV Cohort Study
Oral valganciclovir in children: single dose pharmacokinetics in a six-year-old girl
Burri M, Wiltshire H, Kahlert C, Wouters G, Rudin C. Oral valganciclovir in children: single dose pharmacokinetics in a six-year-old girl. The Pediatric infectious disease journal 2004; 23:263-6.
01.03.2004Oral valganciclovir in children: single dose pharmacokinetics in a six-year-old girl
01.03.2004The Pediatric infectious disease journal 2004; 23:263-6
Burri Marcus, Wiltshire Hugh, Kahlert Christian, Wouters George, Rudin Christoph
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study
Young J, Bucher H, Battegay M, Vernazza P, Telenti A, Hirschel B, Bernasconi E, Furrer H, Rickenbach M, Flepp M, Spirig R, De Geest S, Swiss HIV Cohort Study Group. Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study. BMJ (Clinical research ed.) 2004; 328:15.
03.01.2004Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study
03.01.2004BMJ (Clinical research ed.) 2004; 328:15
Young Jim, Bucher Heiner C, Battegay Manuel, Vernazza Pietro, Telenti Amalio, Hirschel Bernard, Bernasconi Enos, Furrer Hansjakob, Rickenbach Martin, Flepp Markus, Spirig Rebecca, De Geest Sabina, Swiss HIV Cohort Study Group
Ritonavir boosted Indinavir treatment as a simplified maintance „mono“-therapy for HIV infection
Kahlert C, Hupfer M, Wagels T, Büche D, Fierz W, Walker U, Vernazza P. Ritonavir boosted Indinavir treatment as a simplified maintance „mono“-therapy for HIV infection. AIDS 2004:955-957.
01.01.2004Ritonavir boosted Indinavir treatment as a simplified maintance „mono“-therapy for HIV infection
01.01.2004AIDS 2004:955-957
Kahlert Christian, Hupfer M, Wagels Th, Büche Daniel, Fierz W, Walker U, Vernazza Pietro
The Advanced Nursing Practice Team as a model for HIV/AIDS caregiving in Switzerland
Spirig R, Nicca D, Voggensperger J, Unger M, Werder V, Niepmann S. The Advanced Nursing Practice Team as a model for HIV/AIDS caregiving in Switzerland. The Journal of the Association of Nurses in AIDS Care : JANAC 2004; 15:47-55.
01.01.2004The Advanced Nursing Practice Team as a model for HIV/AIDS caregiving in Switzerland
01.01.2004The Journal of the Association of Nurses in AIDS Care : JANAC 2004; 15:47-55
Spirig Rebecca, Nicca Dunja, Voggensperger Jacqueline, Unger Miriam, Werder Vreni, Niepmann Susanne
Diagnostik der latenten Tuberkulose im neuen Millenium
Hoffmann M, Vernazza P, Fierz W. Diagnostik der latenten Tuberkulose im neuen Millenium. Swiss Med Forum 2003; 3:1244-1247.
10.12.2003Diagnostik der latenten Tuberkulose im neuen Millenium
10.12.2003Swiss Med Forum 2003; 3:1244-1247
Hoffmann Matthias, Vernazza Pietro, Fierz Walter
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial
Ananworanich J, Ebnöther C, Fagard C, Genné D, Khanna N, Perrin L, Phanupak P, Ubolyam S, Vernazza P, Yerly S, Cavassini M, Bernasconi E, Nüesch R, Le Braz M, Chetchotisakd P, Vibhagool A, Wicharuk S, Ruxrungtham K, Furrer H, Cooper D, Hirschel B, Swiss HIV Cohort Study. Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial. AIDS (London, England) 2003; 17:F33-7.
17.10.2003Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial
17.10.2003AIDS (London, England) 2003; 17:F33-7
Ananworanich Jintanat, Ebnöther C, Fagard C, Genné D, Khanna N, Perrin L, Phanupak P, Ubolyam S, Vernazza Pietro, Yerly S, Cavassini M, Bernasconi E, Nüesch Reto, Le Braz Michelle, Chetchotisakd Ploechan, Vibhagool Asda, Wicharuk Saijai, Ruxrungtham Kiat, Furrer Hansjakob, Cooper David, Hirschel Bernard, Swiss HIV Cohort Study
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study
Kaufmann G, Battegay M, Egger M, Rickenbach M, Bernasconi E, Vernazza P, Ledergerber B, Hirschel B, Telenti A, Furrer H, Opravil M, Pantaleo G, Perrin L, Swiss HIV Cohort Study Group. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Archives of internal medicine 2003; 163:2187-95.
13.10.2003CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study
13.10.2003Archives of internal medicine 2003; 163:2187-95
Kaufmann Gilbert R, Battegay Manuel, Egger Matthias, Rickenbach Martin, Bernasconi Enos, Vernazza Pietro, Ledergerber Bruno, Hirschel Bernard, Telenti Amalio, Furrer Hansjakob, Opravil Milos, Pantaleo Guiseppe, Perrin Luc, Swiss HIV Cohort Study Group
[Smoking cessation for HIV infected patients]
Voggensperger J, Nicca D, Battegay M, Zellweger J, Spirig R. [Smoking cessation for HIV infected patients]. Pflege 2003; 16:283-8.
01.10.2003[Smoking cessation for HIV infected patients]
01.10.2003Pflege 2003; 16:283-8
Voggensperger Jacqueline, Nicca Dunja, Battegay M, Zellweger J P, Spirig Rebecca
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population
Jaggy C, Hirschel B, Bernasconi E, Vernazza P, Flepp M, Battegay M, Telenti A, Furrer H, Rickenbach M, Egger M, Schwarz C, Ledergerber B, von Overbeck J, Swiss HIV Cohort Study. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. Lancet 2003; 362:877-8.
13.09.2003Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population
13.09.2003Lancet 2003; 362:877-8
Jaggy Christian, Hirschel Bernard, Bernasconi Enos, Vernazza Pietro, Flepp Markus, Battegay Manuel, Telenti Amalio, Furrer Hans-Jakob, Rickenbach Martin, Egger Matthias, Schwarz Claude, Ledergerber Bruno, von Overbeck Jan, Swiss HIV Cohort Study
Aussergewöhnliche Manifestation eines grosszelligen B-Zell Non-Hodgkin-Lymphoms
Hoffmann M, Auf der Maur M, Oderbolz S, Burri G. Aussergewöhnliche Manifestation eines grosszelligen B-Zell Non-Hodgkin-Lymphoms. Swiss Med Forum 2003; 3:883-884.
10.09.2003Aussergewöhnliche Manifestation eines grosszelligen B-Zell Non-Hodgkin-Lymphoms
10.09.2003Swiss Med Forum 2003; 3:883-884
Hoffmann Matthias, Auf der Maur Markus, Oderbolz Stefan, Burri Gallus
Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial
Dragsted U, Lundgren J, Fox Z, Youle M, Vernazza P, Cassetti I, Hill A, Benetucci J, Bruun J, Clumeck N, Cahn P, Castagna A, Obel N, Duran A, Peters B, Pedersen C, Gerstoft J, MaxCmin1 Trial Group. Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial. The Journal of infectious diseases 2003; 188:635-42.
01.09.2003Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial
01.09.2003The Journal of infectious diseases 2003; 188:635-42
Dragsted Ulrik Bak, Lundgren Jens D, Fox Zoe, Youle Mike, Vernazza Pietro, Cassetti Isabel, Hill Andrew, Benetucci Jorge, Bruun Johan N, Clumeck Nathan, Cahn Pedro, Castagna Antonella, Obel Niels, Duran Adriana, Peters Barry, Pedersen Court, Gerstoft Jan, MaxCmin1 Trial Group
Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study
Wolf K, Bucher H, Weber R, Telenti A, Hirschel B, Bernasconi E, Furrer H, Flepp M, Vernazza P, Rickenbach M, Young J, Swiss HIV Cohort Study. Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes (1999) 2003; 33:494-9.
01.08.2003Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study
01.08.2003Journal of acquired immune deficiency syndromes (1999) 2003; 33:494-9
Wolf Katja, Bucher Heiner C, Weber Rainer, Telenti Amalio, Hirschel Bernard, Bernasconi Enos, Furrer Hansjakob, Flepp Markus, Vernazza Pietro, Rickenbach Martin, Young James, Swiss HIV Cohort Study
Antiretroviral therapy to reduce the sexual transmission of HIV
Taylor S, Boffito M, Vernazza P. Antiretroviral therapy to reduce the sexual transmission of HIV. Journal of HIV therapy 2003; 8:55-66.
01.08.2003Antiretroviral therapy to reduce the sexual transmission of HIV
01.08.2003Journal of HIV therapy 2003; 8:55-66
Taylor Stephen, Boffito Marta, Vernazza Pietro
A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART
Fagard C, Hirschel B, Perrin L, Perneger T, Oxenius A, Ebnöther C, Telenti A, Bernasconi E, Vernazza P, Egger M, Hirsch H, Günthard H, Le Braz M, Swiss HIV Cohort Study. A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART. AIDS (London, England) 2003; 17:1487-92.
04.07.2003A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART
04.07.2003AIDS (London, England) 2003; 17:1487-92
Fagard Catherine, Hirschel Bernard, Perrin Luc, Perneger Thomas, Oxenius Annette, Ebnöther Corinna, Telenti Amalio, Bernasconi Enos, Vernazza Pietro, Egger Martin, Hirsch Hans H, Günthard Huldrych, Le Braz Michelle, Swiss HIV Cohort Study
Rho protein-mediated changes in the structure of the actin cytoskeleton regulate human inducible NO synthase gene expression
Witteck A, Yao Y, Fechir M, Förstermann U, Kleinert H. Rho protein-mediated changes in the structure of the actin cytoskeleton regulate human inducible NO synthase gene expression. Experimental cell research 2003; 287:106-15.
01.07.2003Rho protein-mediated changes in the structure of the actin cytoskeleton regulate human inducible NO synthase gene expression
01.07.2003Experimental cell research 2003; 287:106-15
Witteck Andrea, Yao Ying, Fechir Marcel, Förstermann Ulrich, Kleinert Hartmut